Myocarditis in Adult-Onset Still’s Disease: Case-Based Review
Cardiac involvement in adult-onset Still’s disease (AOSD) usually manifests as a pericardial disease. Myocarditis is uncommon (prevalence of 7%). However, the cardiocirculatory failure is the second cause of life-threatening AOSD. Herein, we report the case of a 38-year-old man who was diagnosed with myocarditis caused by AOSD. He was treated medically with steroids and methotrexate, and his course was favorable. A literature search in PubMed/MEDLINE and Scopus databases from 1971 to 2019 identified 47 additional cases of myocarditis and AOSD. The main features found in these reports were reviewed and are the following: (i) myocarditis is a rare complication of AOSD manifested by fever, chest pain, dyspnea, and tachycardia; (ii) cardiac biomarkers, electrocardiogram (ECG), transthroracic echocardiography (ECHO), and cardiac magnetic resonance imaging (MRI) are useful noninvasive diagnostic tools; and (iii) myocarditis is a potentially life-threatening complication of AOSD but responds positively to steroids and other immunomodulatory drugs. This review suggests that this entity should be suspected in cases of acute febrile myocarditis after ruling out other causes since a prompt treatment results in a good prognosis.
KeywordsAdult-onset Heart diseases Myocarditis Still’s Disease
The case was diagnosed and followed up by AEGR and JACO, and AEGR conceived and planned the case report. Material preparation, data collection, and analysis were performed by AEGR and JACO. AEGR wrote the initial draft of the manuscript. JACO revised and edited the manuscript. The final version was read, corrected, and approved by both authors, and both agree to be accountable for all aspects of the work.
The authors received no financial support for the research, authorship, and/or publication of this article.
Compliance with ethical standards
Ethics approval and consent to participate
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent for publication has been obtained from the patient, in line with the COPE best practice guidelines.
- 10.Néel A, Wahbi A, Tessoulin B, Boileau J, Carpentier D, Decaux O, Fardet L, Geri G, Godmer P, Goujard C, Maisonneuve H, Mari A, Pouchot J, Ziza JM, Bretonnière C, Hamidou M (2018) Diagnostic and management of life-threatening Adult-Onset Still Disease: a French nationwide multicenter study and systematic literature review. Crit Care 22(1):88. https://doi.org/10.1186/s13054-018-2012-2 CrossRefPubMedPubMedCentralGoogle Scholar
- 11.Bilgin E, Hayran M, Erden A, Armağan B, Sarı A, Kılıç L, Akdoğan A, Karadağ Ö, Bilgen ŞA, Kiraz S, Ertenli İ, Kalyoncu U (2019) Proposal for a simple algorithm to differentiate adult-onset Still’s disease with other fever of unknown origin causes: a longitudinal prospective study. Clin Rheumatol 38(6):1699–1706. https://doi.org/10.1007/s10067-019-04455-y CrossRefPubMedGoogle Scholar
- 50.Parisi F, Paglionico A, Varriano V, Ferraccioli G, Gremese E (2017) Refractory adult-onset Still disease complicated by macrophage activation syndrome and acute myocarditis: a case report treated with high doses (8 mg/kg/d) of anakinra. Medicine 96(24):e6656. https://doi.org/10.1097/MD.0000000000006656 CrossRefPubMedPubMedCentralGoogle Scholar
- 52.Piel-Julian ML, Moulis G, Fournier P, Dupont R, Geiger D, Astudillo L, Faurie T, Pozzo J, Petermann A, Lairez O, Pugnet G, Sailler L (2018) Early use of anakinra in adult-onset Still’s disease myocarditis. Scand J Rheumatol 47(6):511–512. https://doi.org/10.1080/03009742.2017.1387672 CrossRefPubMedGoogle Scholar
- 58.Sfriso P, Priori R, Valesini G, Rossi S, Montecucco CM, D'Ascanio A, Carli L, Bombardieri S, LaSelva G, Iannone F, Lapadula G, Alivernini S, Ferraccioli G, Colaci M, Ferri C, Iacono D, Valentini G, Costa L, Scarpa R, LoMonaco A, Bagnari V, Govoni M, Piazza I, Adami S, Ciccia F, Triolo G, Alessandri E, Cutolo M, Cantarini L, Galeazzi M, Ruscitti P, Giacomelli R, Caso F, Galozzi P, Punzi L (2016) Adult-onset Still’s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients. Clin Rheumatol 35(7):1683–1689. https://doi.org/10.1007/s10067-016-3308-8 CrossRefPubMedGoogle Scholar
- 61.Friedrich MG, Sechtem U, Schulz-Menger J, Holmvang G, Alakija P, Cooper LT, White JA, Abdel-Aty H, Gutberlet M, Prasad S, Aletras A, Laissy JP, Paterson I, Filipchuk NG, Kumar A, Pauschinger M, Liu P, International Consensus Group on Cardiovascular Magnetic Resonance in Myocarditis (2009) Cardiovascular magnetic resonance in myocarditis: a JACC White Paper. J Am Coll Cardiol 53(17):1475–1487. https://doi.org/10.1016/j.jacc.2009.02.007 CrossRefPubMedPubMedCentralGoogle Scholar
- 63.Caforio AL, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, Fu M, Heliö T, Heymans S, Jahns R, Klingel K, Linhart A, Maisch B, McKenna W, Mogensen J, Pinto YM, Ristic A, Schultheiss HP, Seggewiss H, Tavazzi L, Thiene G, Yilmaz A, Charron P, Elliott PM, European Society of Cardiology Working Group on Myocardial and Pericardial Diseases (2013) Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 34(33):2636–2648. https://doi.org/10.1093/eurheartj/eht210 CrossRefPubMedGoogle Scholar
- 65.Goda K, Kenzaka T, Hoshijima M, Yachie A, Akita H (2019) Adult-onset Still’s disease with macrophage activation syndrome diagnosed and treated based on cytokine profiling: a case-based review. Rheumatol Int. https://doi.org/10.1007/s00296-019-04446-x
- 67.Mimura T, Kondo Y, Ohta A, Iwamoto M, Ota A, Okamoto N, Kawaguchi Y, Kono H, Takasaki Y, Takei S, Nishimoto N, Fujimoto M, Asanuma YF, Mimori A, Okiyama N, Kaneko S, Takahashi H, Yokosawa M, Sumida T (2018) Evidence-based clinical practice guideline for adult Still’s disease. Mod Rheumatol 28(5):736–757. https://doi.org/10.1080/14397595.2018.1465633 CrossRefPubMedGoogle Scholar
- 68.Dall'Ara F, Frassi M, Tincani A, Airò P (2016) A retrospective study of patients with adult-onset Still’s disease: is pericarditis a possible predictor for biological disease-modifying anti-rheumatic drugs need? Clin Rheumatol 35(8):2117–2123. https://doi.org/10.1007/s10067-015-3164-y CrossRefPubMedGoogle Scholar